| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA901498 | F | Antiparasitic activity against Trypanosoma brucei rhodesiense STIB900 in blood | Trypanosoma brucei rhodesiense | 18 | ALA1138251 | organism-based format | Scientific Literature | |
| 2. | ALA901499 | F | Antiparasitic activity against Trypanosoma brucei rhodesiense STIB900 in procyclic stage | Trypanosoma brucei rhodesiense | 18 | ALA1138251 | organism-based format | Scientific Literature | |
| 3. | ALA901500 | F | Antiparasitic activity against Trypanosoma cruzi Tulahuen T4 in amastigotes stage | Trypanosoma cruzi | 18 | ALA1138251 | organism-based format | Scientific Literature | |
| 4. | ALA901501 | F | Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 in amastigotes stage | Leishmania donovani | 18 | ALA1138251 | organism-based format | Scientific Literature | |
| 5. | ALA901502 | F | Antiparasitic activity against chloroquine, pyrimethamine-resistant Plasmodium falciparum K1 erythrocyte stage infected rat L6 cells | Plasmodium falciparum | 18 | ALA1138251 | organism-based format | Scientific Literature | |
| 6. | ALA901503 | A | Cytotoxicity against rat L6 cells | Rattus norvegicus | 18 | ALA1138251 | cell-based format | Scientific Literature | |
| 7. | ALA3832785 | F | AntiTrypanosoma cruzi activity IC50 (uM) | Trypanosoma cruzi | 65 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 8. | ALA3832786 | F | AntiTrypanosoma brucei activity T. b. brucei IC50 (uM) | Trypanosoma brucei | 64 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 9. | ALA3832787 | F | AntiTrypanosoma brucei activity T. b. rhodesiense IC50 (uM) | Trypanosoma brucei | 62 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 10. | ALA3832788 | F | AntiLeishmania activity L. major IC50 (uM) | Leishmania major | 6 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 11. | ALA3832789 | F | AntiLeishmania activity L. infantum (macrophages) IC50 (uM) | Leishmania infantum | 65 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 12. | ALA3832790 | F | AntiLeishmania activity L. donovani (axenic) IC50 (uM) | Leishmania donovani | 14 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 13. | ALA3832791 | F | AntiLeishmania activity L. donovani (macrophages) IC50 (uM) | Leishmania donovani | 14 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 14. | ALA3832792 | F | AntiLeishmania activity Toxicity on infected PMM (uM) | Leishmania | 14 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 15. | ALA3832830 | F | Cytotoxicity data HepG2 CC20 (uM) | 172 | ALA3832761 | cell-based format | MMV Pathogen Box | ||
| 16. | ALA3832841 | F | L6 CC50 (uM) Cytotoxicity | 14 | ALA3832761 | cell-based format | MMV Pathogen Box | ||
| 17. | ALA3832842 | F | MRC5 CC50 (uM) Cytotoxicity | 77 | ALA3832761 | cell-based format | MMV Pathogen Box | ||
| 18. | ALA3832843 | F | PMM CC50 (uM) Cytotoxicity | 65 | ALA3832761 | cell-based format | MMV Pathogen Box | ||
| 19. | ALA3987222 | B | Compound was evaluated for the inhibition of human FECH at 10uM | Homo sapiens | 400 | ALA3987221 | single protein format | MMV Pathogen Box | |
| 20. | ALA3987223 | B | Compound was evaluated for the inhibition of human HMBS at 100uM | Homo sapiens | 400 | ALA3987221 | assay format | MMV Pathogen Box |
The page will load shortly, Thanks for your patience!